Señales en vivo de WXXWY | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 15:59):

Stats
Volumen de hoy	53 686.00
Volumen promedio	181 101
Capitalización de mercado	7.54B
Próxima fecha de ganancias	( $0 ) 2024-06-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	13.62
ATR14	$0.00600 (0.17%)

Volumen Correlación

Largo: 0.20 (neutral)

Corto: -0.80 (strong negative)

Signal:(55.945) Neutral

WuXi Biologics (Cayman) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

WuXi Biologics (Cayman) Correlación - Moneda/Commodity

-0.64
( weak negative )

-0.69
( moderate negative )

0.00
( neutral )

-0.20
( neutral )

0.61
( weak )

WuXi Biologics (Cayman) Finanzas

Annual	2022
Ingresos:	$15.27B
Beneficio Bruto:	$6.72B (44.04 %)
EPS:	$1.060

FY	2022
Ingresos:	$15.27B
Beneficio Bruto:	$6.72B (44.04 %)
EPS:	$1.060

FY	2021
Ingresos:	$10.29B
Beneficio Bruto:	$4.83B (46.93 %)
EPS:	$1.714

FY	2020
Ingresos:	$5.61B
Beneficio Bruto:	$2.53B (45.13 %)
EPS:	$0.860

Financial Reports:

No articles found.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.